Prognosis of Relapsing Neuromyelitis Optica

Abstract

Clinical predictors of a relapsing course and subsequent survival in 80 patients with neuromyelitis optica (NMO) (57 relapsing, 23 monophasic) were developed from a study of medical records and patients at the Mayo Clinic, Scottsdale, AZ.

Keywords

• neuromyelitis optica
• relapsing
• autoimmune disease